InvestorsHub Logo
Followers 70
Posts 11718
Boards Moderated 0
Alias Born 01/05/2018

Re: midwestice post# 387955

Tuesday, 02/08/2022 7:30:08 PM

Tuesday, February 08, 2022 7:30:08 PM

Post# of 403599
Would not even know what they would offer, but it definitely would be lowballed since the share price is beat down. If they were to offer $4.00 per share for Everything excluding the indication and method that currently is licensed to another Pharma, I feel that would be a win right now in my opinion. It would be a loss for all the Longs who have not averaged down as of late, but for the newbie investors and for those that have averaged down and invested more, it will be a very nice win. I’ve personally averaged down myself greatly since I feel Brilacidin can one day be a platform type drug, and Kevetrin can one day be bigger than Keytruda. But at this present moment in time and where the company’s finances are, I would be happy to see the $4.00 per share buyout as things stand now. Just my opinion. If government funding or another form of non-dilutive funding comes along, than all bets are off.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News